Literature DB >> 9423886

Analysis of inhibitory epitopes in the Plasmodium falciparum rhoptry protein RAP-1 including identification of a second inhibitory epitope.

R F Howard1, K C Jacobson, E Rickel, J Thurman.   

Abstract

Immune responses to Plasmodium falciparum rhoptry-associated protein 1 (RAP-1), RAP-2, and RAP-3 appear to contribute to protection against infection by this human malarial parasite. This conclusion is suggested by results of monkey immunization trials and of cell culture studies showing antibody-dependent inhibition of erythrocyte invasion. In the present study, splenectomized owl monkeys were infected with P. falciparum in order to monitor anti-RAP-1 antibody production as antiparasite immunity developed. The monkeys responded to a primary infection with the production of antibodies to a fragment of RAP-1 containing amino acids 1 to 294 (RAP-1(1-294)). After drug cure and reinfection, the monkeys had a prolonged prepatent period, indicating they had already developed partial immunity to the parasite. Sera from these animals showed major increases in anti-RAP-1(1-294) antibodies. In contrast, only low levels of antibodies to inhibitory B-cell epitope 1 (iB-1), an inhibitory epitope in RAP-1(1-294) with the sequence N200TLTPLEELYPT211, was observed after the initial parasite infection, and the anti-iB-1 antibodies were not readily boosted upon reinfection. These results suggest that iB-1 is an immunogenic but not immunodominant epitope and that anti-iB-1 antibodies do not substantially contribute to early stages of naturally acquired immunity in the owl monkey model. To identify additional epitopes bound by inhibitory antibodies, mouse monoclonal antibodies were produced with a recombinant fusion protein containing RAP-1(1-294). Monoclonal antibody 1D6 inhibited parasite invasion of erythrocytes in vitro. 1D6 did not bind peptide iB-1 but rather bound a second inhibitory epitope called iB-2. iB-2, like iB-1, is found near the amino terminus of p67, a RAP-1 processing product thought to be involved in merozoite invasion of erythrocytes. Since anti-iB-1 antibodies were not readily produced during parasite infection, it may be desirable to direct antibody responses to particular epitopes in RAP-1, such as iB-1 and iB-2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9423886      PMCID: PMC107910     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Isolation of stages of the human parasite Plasmodium falciparum from culture and from animal blood.

Authors:  R T Reese; S G Langreth; W Trager
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

2.  Target antigens for asexual malaria vaccine development.

Authors:  R J Howard; B L Pasloske
Journal:  Parasitol Today       Date:  1993-10

3.  Characterisation and sequence of a protective rhoptry antigen from Plasmodium falciparum.

Authors:  R G Ridley; B Takacs; H W Lahm; C J Delves; M Goman; U Certa; H Matile; G R Woollett; J G Scaife
Journal:  Mol Biochem Parasitol       Date:  1990-06       Impact factor: 1.759

4.  The sequence of the p82 rhoptry protein is highly conserved between two Plasmodium falciparum isolates.

Authors:  R F Howard
Journal:  Mol Biochem Parasitol       Date:  1992-04       Impact factor: 1.759

5.  Genetic and structural relationships between components of a protective rhoptry antigen complex from Plasmodium falciparum.

Authors:  R G Ridley; H W Lahm; B Takács; J G Scaife
Journal:  Mol Biochem Parasitol       Date:  1991-08       Impact factor: 1.759

6.  Fc receptors for mouse IgG1 on human monocytes: polymorphism and role in antibody-induced T cell proliferation.

Authors:  W J Tax; F F Hermes; R W Willems; P J Capel; R A Koene
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

7.  Three matrix metalloproteinases form a non-covalent association with the rhoptry-associated protein-1 of Plasmodium falciparum.

Authors:  C P Locher; F Vandekerckhove; L Q Tam
Journal:  Biochim Biophys Acta       Date:  1992-12-28

8.  Stable antibody-producing murine hybridomas.

Authors:  R T Taggart; I M Samloff
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

9.  Monoclonal antibody characterization of Plasmodium falciparum antigens.

Authors:  G H Campbell; L H Miller; D Hudson; E L Franco; P M Andrysiak
Journal:  Am J Trop Med Hyg       Date:  1984-11       Impact factor: 2.345

10.  Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.

Authors:  M J Blackman; T J Scott-Finnigan; S Shai; A A Holder
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  10 in total

1.  Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro.

Authors:  R Moreno; F Pöltl-Frank; D Stüber; H Matile; M Mutz; N A Weiss; G Pluschke
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Interaction of HLA and age on levels of antibody to Plasmodium falciparum rhoptry-associated proteins 1 and 2.

Authors:  A Johnson; R Leke; L Harun; C Ginsberg; J Ngogang; A Stowers; A Saul; I A Quakyi
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  RAP1 controls rhoptry targeting of RAP2 in the malaria parasite Plasmodium falciparum.

Authors:  D L Baldi; K T Andrews; R F Waller; D S Roos; R F Howard; B S Crabb; A F Cowman
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

4.  Evidence for negative selection on the gene encoding rhoptry-associated protein 1 (RAP-1) in Plasmodium spp.

Authors:  M Andreína Pacheco; Elizabeth M Ryan; Amanda C Poe; Leonardo Basco; Venkatachalam Udhayakumar; Williams E Collins; Ananias A Escalante
Journal:  Infect Genet Evol       Date:  2010-04-02       Impact factor: 3.342

5.  Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens.

Authors:  Angela Trieu; Matthew A Kayala; Chad Burk; Douglas M Molina; Daniel A Freilich; Thomas L Richie; Pierre Baldi; Philip L Felgner; Denise L Doolan
Journal:  Mol Cell Proteomics       Date:  2011-05-31       Impact factor: 5.911

6.  Multiple antigen peptide vaccines against Plasmodium falciparum malaria.

Authors:  Babita Mahajan; Jay A Berzofsky; Robert A Boykins; Victoria Majam; Hong Zheng; Rana Chattopadhyay; Patricia de la Vega; J Kathleen Moch; J David Haynes; Igor M Belyakov; Hira L Nakhasi; Sanjai Kumar
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

7.  Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development.

Authors:  Alan F Cowman; Deborah L Baldi; Manoj Duraisingh; Julie Healer; Kerry E Mills; Rebecca A O'Donnell; Jennifer Thompson; Tony Triglia; Mark E Wickham; Brendan S Crabb
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-01-29       Impact factor: 6.237

8.  Associations between responses to the rhoptry-associated membrane antigen of Plasmodium falciparum and immunity to malaria infection.

Authors:  Agnieszka E Topolska; Thomas L Richie; Doan Hanh Nhan; Ross L Coppel
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

9.  A longitudinal study of human antibody responses to Plasmodium falciparum rhoptry-associated protein 1 in a region of seasonal and unstable malaria transmission.

Authors:  P N Fonjungo; I M Elhassan; D R Cavanagh; T G Theander; L Hviid; C Roper; D E Arnot; J S McBride
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

10.  The persistence of naturally acquired antibodies and memory B cells specific to rhoptry proteins of Plasmodium vivax in patients from areas of low malaria transmission.

Authors:  Piyawan Kochayoo; Siriruk Changrob; Kittikorn Wangriatisak; Seong Kyun Lee; Patchanee Chootong; Eun-Taek Han
Journal:  Malar J       Date:  2019-11-29       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.